Response to Diaz-Arrastia et al., "Pharmacotherapy of traumatic brain injury: state of the science and the road forward"
Gespeichert in:
| Veröffentlicht in: | Journal of neurotrauma 2014-11, Vol.31 (22), p.1896-1896 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1896 |
|---|---|
| container_issue | 22 |
| container_start_page | 1896 |
| container_title | Journal of neurotrauma |
| container_volume | 31 |
| creator | Tapia Pérez, J Humberto Aguilar, Martin Sánchez Schneider, Thomas |
| description | |
| doi_str_mv | 10.1089/neu.2014.3342 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1622066086</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3485335011</sourcerecordid><originalsourceid>FETCH-LOGICAL-c277t-db63f84796c54ada0c5cbebec61c514c075a5b65a48ca33f645dc096afbbb3e23</originalsourceid><addsrcrecordid>eNpd0c9LHDEUwPFQKrpVj14l2EsPzja_M-NNtFVBsIieh5fMG3aWnck2yVDXv95ZtR48hUc-PEK-hBxxNuesrH4OOM4F42oupRJfyIxrbYuKKfGVzKZ7W1iu-R75ltKSMS6NsLtkT6iKl4aVM_J0j2kdhoQ0B3rZwXNxHiOk3AHFTGE1P6UnfxYQe_AhLzDCekNDS3OEsYfceeoidAPthuUYN2c0Zcj4ChZIk-9w8EhhaF7nGKChbYj_IDYnB2SnhVXCw_dznzz-_vVwcV3c3l3dXJzfFl5Ym4vGGdmWylbGawUNMK-9Q4fecK-58sxq0M5oUKUHKVujdONZZaB1zkkUcp_8eNu7juHviCnXfZc8rlYwYBhTzY0QzEx_YSb6_RNdhjEO0-u2iiuurWGTKt6UjyGliG29jl0PcVNzVm-T1FOSepuk3iaZ_PH71tH12Hzo_w3kC8cjh5A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1621415760</pqid></control><display><type>article</type><title>Response to Diaz-Arrastia et al., "Pharmacotherapy of traumatic brain injury: state of the science and the road forward"</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Tapia Pérez, J Humberto ; Aguilar, Martin Sánchez ; Schneider, Thomas</creator><creatorcontrib>Tapia Pérez, J Humberto ; Aguilar, Martin Sánchez ; Schneider, Thomas</creatorcontrib><identifier>ISSN: 0897-7151</identifier><identifier>EISSN: 1557-9042</identifier><identifier>DOI: 10.1089/neu.2014.3342</identifier><identifier>PMID: 24918608</identifier><language>eng</language><publisher>United States: Mary Ann Liebert, Inc</publisher><subject>Amnesia - prevention & control ; Biomedical Research - standards ; Brain Injuries - drug therapy ; Brain Injuries - psychology ; Confusion - prevention & control ; Fluorobenzenes - therapeutic use ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use ; Neuropharmacology - standards ; Pyrimidines - therapeutic use ; Sulfonamides - therapeutic use ; United States Department of Defense - standards</subject><ispartof>Journal of neurotrauma, 2014-11, Vol.31 (22), p.1896-1896</ispartof><rights>(©) Copyright 2014, Mary Ann Liebert, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c277t-db63f84796c54ada0c5cbebec61c514c075a5b65a48ca33f645dc096afbbb3e23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24918608$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tapia Pérez, J Humberto</creatorcontrib><creatorcontrib>Aguilar, Martin Sánchez</creatorcontrib><creatorcontrib>Schneider, Thomas</creatorcontrib><title>Response to Diaz-Arrastia et al., "Pharmacotherapy of traumatic brain injury: state of the science and the road forward"</title><title>Journal of neurotrauma</title><addtitle>J Neurotrauma</addtitle><subject>Amnesia - prevention & control</subject><subject>Biomedical Research - standards</subject><subject>Brain Injuries - drug therapy</subject><subject>Brain Injuries - psychology</subject><subject>Confusion - prevention & control</subject><subject>Fluorobenzenes - therapeutic use</subject><subject>Humans</subject><subject>Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use</subject><subject>Neuropharmacology - standards</subject><subject>Pyrimidines - therapeutic use</subject><subject>Sulfonamides - therapeutic use</subject><subject>United States Department of Defense - standards</subject><issn>0897-7151</issn><issn>1557-9042</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNpd0c9LHDEUwPFQKrpVj14l2EsPzja_M-NNtFVBsIieh5fMG3aWnck2yVDXv95ZtR48hUc-PEK-hBxxNuesrH4OOM4F42oupRJfyIxrbYuKKfGVzKZ7W1iu-R75ltKSMS6NsLtkT6iKl4aVM_J0j2kdhoQ0B3rZwXNxHiOk3AHFTGE1P6UnfxYQe_AhLzDCekNDS3OEsYfceeoidAPthuUYN2c0Zcj4ChZIk-9w8EhhaF7nGKChbYj_IDYnB2SnhVXCw_dznzz-_vVwcV3c3l3dXJzfFl5Ym4vGGdmWylbGawUNMK-9Q4fecK-58sxq0M5oUKUHKVujdONZZaB1zkkUcp_8eNu7juHviCnXfZc8rlYwYBhTzY0QzEx_YSb6_RNdhjEO0-u2iiuurWGTKt6UjyGliG29jl0PcVNzVm-T1FOSepuk3iaZ_PH71tH12Hzo_w3kC8cjh5A</recordid><startdate>20141115</startdate><enddate>20141115</enddate><creator>Tapia Pérez, J Humberto</creator><creator>Aguilar, Martin Sánchez</creator><creator>Schneider, Thomas</creator><general>Mary Ann Liebert, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20141115</creationdate><title>Response to Diaz-Arrastia et al., "Pharmacotherapy of traumatic brain injury: state of the science and the road forward"</title><author>Tapia Pérez, J Humberto ; Aguilar, Martin Sánchez ; Schneider, Thomas</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c277t-db63f84796c54ada0c5cbebec61c514c075a5b65a48ca33f645dc096afbbb3e23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Amnesia - prevention & control</topic><topic>Biomedical Research - standards</topic><topic>Brain Injuries - drug therapy</topic><topic>Brain Injuries - psychology</topic><topic>Confusion - prevention & control</topic><topic>Fluorobenzenes - therapeutic use</topic><topic>Humans</topic><topic>Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use</topic><topic>Neuropharmacology - standards</topic><topic>Pyrimidines - therapeutic use</topic><topic>Sulfonamides - therapeutic use</topic><topic>United States Department of Defense - standards</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tapia Pérez, J Humberto</creatorcontrib><creatorcontrib>Aguilar, Martin Sánchez</creatorcontrib><creatorcontrib>Schneider, Thomas</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of neurotrauma</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tapia Pérez, J Humberto</au><au>Aguilar, Martin Sánchez</au><au>Schneider, Thomas</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Response to Diaz-Arrastia et al., "Pharmacotherapy of traumatic brain injury: state of the science and the road forward"</atitle><jtitle>Journal of neurotrauma</jtitle><addtitle>J Neurotrauma</addtitle><date>2014-11-15</date><risdate>2014</risdate><volume>31</volume><issue>22</issue><spage>1896</spage><epage>1896</epage><pages>1896-1896</pages><issn>0897-7151</issn><eissn>1557-9042</eissn><cop>United States</cop><pub>Mary Ann Liebert, Inc</pub><pmid>24918608</pmid><doi>10.1089/neu.2014.3342</doi><tpages>1</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0897-7151 |
| ispartof | Journal of neurotrauma, 2014-11, Vol.31 (22), p.1896-1896 |
| issn | 0897-7151 1557-9042 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1622066086 |
| source | MEDLINE; Alma/SFX Local Collection |
| subjects | Amnesia - prevention & control Biomedical Research - standards Brain Injuries - drug therapy Brain Injuries - psychology Confusion - prevention & control Fluorobenzenes - therapeutic use Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use Neuropharmacology - standards Pyrimidines - therapeutic use Sulfonamides - therapeutic use United States Department of Defense - standards |
| title | Response to Diaz-Arrastia et al., "Pharmacotherapy of traumatic brain injury: state of the science and the road forward" |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T18%3A36%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Response%20to%20Diaz-Arrastia%20et%20al.,%20%22Pharmacotherapy%20of%20traumatic%20brain%20injury:%20state%20of%20the%20science%20and%20the%20road%20forward%22&rft.jtitle=Journal%20of%20neurotrauma&rft.au=Tapia%20P%C3%A9rez,%20J%20Humberto&rft.date=2014-11-15&rft.volume=31&rft.issue=22&rft.spage=1896&rft.epage=1896&rft.pages=1896-1896&rft.issn=0897-7151&rft.eissn=1557-9042&rft_id=info:doi/10.1089/neu.2014.3342&rft_dat=%3Cproquest_cross%3E3485335011%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1621415760&rft_id=info:pmid/24918608&rfr_iscdi=true |